Page last updated: 2024-09-04

an-69 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

an-69 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(an-69)
Trials
(an-69)
Recent Studies (post-2010)
(an-69)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
1472899,156187552

Protein Interaction Comparison

ProteinTaxonomyan-69 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afentakis, N; Antonopoulou, S; Dinas, C; Iatrou, C; Nomikos, T; Stavropoulos-Giokas, C1

Trials

1 trial(s) available for an-69 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Nephron, 2002, Volume: 91, Issue:1

    Topics: Acrylic Resins; Acrylonitrile; Adult; Aged; Cellulose; Complement Activation; Complement C3a; Complement Membrane Attack Complex; Female; Humans; Leukocyte Count; Male; Membranes, Artificial; Middle Aged; Platelet Activating Factor; Platelet Count; Renal Dialysis

2002